10 employees
ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.
2012
$4.8M
from 1 investors over 1 rounds
ILC Therapeutics Ltd raised $4.8M on September 6, 2021
Investors: Scottish Enterprise